Advanced Clinical

Clinical Research Associate (CRA) - Remote-based in Midwest (will also consider CA or TX)

US-Nationwide
Req No.
2017-7945
Category
Biotech/R&D/Science
Type
Regular Full-Time

Overview

A Clinical Research Associate (CRA) is responsible for conducting monitoring activities at a clinical site(s) for a clinical trial(s).The CRA may be responsible for multiple projects and must be able to work both independently and in a team environment.

Responsibilities

  • Follow Standard Operating Procedures (SOPs)
  • Travel to research sites as needed.
  • Attend project-specific training and client meetings as needed for the clinical trial.
  • Create materials as needed to successfully execute assigned responsibilities.
  • Perform source data verification, review regulatory documents and study drug, and prepare trip reports as outlined in the Monitoring Plan

Qualifications

The ideal candidate should have a Bachelor’s degree but an RN may be considered. Prefer scientific discipline and multiple therapeutic experiences. Three (3) or more years of monitoring experience in oncology or combination of on-site monitoring and clinical research experience or education; industry certification preferred.  The ability to perform national travel up to an average of 80%, depending on project needs.  The candidate must have excellent verbal and written communications skills; excellent interpersonal and organizational skills with demonstrated attention to detail.  The candidate must be computer literate with proficiency in MS Office including Word, Excel, and PowerPoint.

 

What we Offer:

  • Outstanding compensation package
  • Cutting edge tools & software
  • On-going training & development
  • Work Life Balance – Ability to work from home
  • Regionally based travel
  • Strong national client base & name recognition
  • Excellent Benefits – Medical / Dental / Vision / 401K / Vacation

 

For a complete list of all of our job openings, please click here

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed